cinnabarinic acid has been researched along with Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baymeeva, NV; Brusov, OS; Oleichik, IV; Shilov, YE; Sizov, SV; Tyurin, IA | 1 |
| Antenucci, N; Battaglia, G; Bruno, V; Chocyk, A; Cieslik, P; Curto, M; Di Menna, L; Fazio, F; Fucile, S; Giannino, G; Iacovelli, L; Liberatore, F; Lionetto, L; Martinello, K; Mascio, G; Nicoletti, F; Pilc, A; Pittaluga, A; Simmaco, M; Traficante, A; Ulivieri, M; Vergassola, M; WieroĊska, JM | 1 |
2 other study(ies) available for cinnabarinic acid and Schizophrenia
| Article | Year |
|---|---|
[Cinnabarinic acid as a potential prognostic marker of schizophrenia].
Topics: 3-Hydroxyanthranilic Acid; Female; Humans; Kynurenine; Oxazines; Prognosis; Schizophrenia | 2022 |
The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia.
Topics: Adult; Animals; Antipsychotic Agents; Behavior, Animal; Cells, Cultured; Disease Models, Animal; Electrophysiological Phenomena; Female; Humans; Kynurenine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Oxazines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Schizophrenia; Tissue Banks | 2020 |